Magnetar Financial’s Cidara Therapeutics CDTX Stock Holding History

Magnetar Financial’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-232,537	Closed	-$51.4M	–	1180
2025 Q4	$51.4M	Buy	+232,537	New	+$37.6M	0.5%	27

Magnetar Financial's CDTX Position: Q1 2026 in Review

Magnetar Financial sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 232,537 shares — an estimated $51.4M sold.

Magnetar Financial first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $51.4M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Magnetar Financial reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Magnetar Financial sold 232,537 Cidara Therapeutics shares in Q1 2026, an estimated $51.4M.
Magnetar Financial first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Magnetar Financial's Cidara Therapeutics position peaked at $51.4M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.